No Data
Jianmin Group: Summary of Jianmin Group\'s 2024 Annual Report
Jianmin Group: Jianmin Group 2024 Annual Report
Jianmin Group Annual Report 2024
Jianmin Group 2024 Annual Report Summary
Jianmin Pharmaceutical Group (600976.SH): The net income in 2024 is 0.362 billion yuan, a year-on-year decrease of 30.54%. A proposal to distribute 9 yuan per share.
Gelonghui March 21丨Jianmin Pharmaceutical Group (600976.SH) announced its annual report for 2024, reporting revenue of 3.505 billion yuan, a year-on-year decrease of 16.81%; net income attributable to shareholders of the listed company was 0.362 billion yuan, a year-on-year decrease of 30.54%; basic EPS was 2.38 yuan. It is proposed to distribute a cash dividend of 9.00 yuan (including tax) for every 10 shares to all shareholders.
Jianmin Pharmaceutical GroupLtd's (SHSE:600976) 25% CAGR Outpaced the Company's Earnings Growth Over the Same Five-year Period
Jianmin Pharmaceutical GroupLtd's (SHSE:600976) Solid Profits Have Weak Fundamentals